Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Diabetes. Mar 15, 2012; 3(3): 54-59
Published online Mar 15, 2012. doi: 10.4239/wjd.v3.i3.54
Published online Mar 15, 2012. doi: 10.4239/wjd.v3.i3.54
ApoE isoforms, treatment of diabetes and the risk of coronary heart disease
Hideki Ehara, Hiroji Kitazato, Shoji Kawazu, Yasuo Akanuma, the Institute for Adult Diseases, Asahi Life Foundation, 2-2-6, Nihonbashi-bakurocho, Chuo-ku, Tokyo 103-0002, Japan
Hideki Ehara, Ehara Medical Clinic, 1-10 Shouwa-cho, Tuyama-city, Okayama 708-0886, Japan
Ritsuko Yamamoto-Honda, Yoshihiko Takahashi, Mitsuhiko Noda, Department of Diabetes and Metabolic Medicine and Diabetes Research Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan
Hiroji Kitazato, Department of Diabetes and Endocrinology, Oomori Red Cross Hospital 4-30-11 Chuo, Oota-ku, Tokyo 143-8527, Japan
Author contributions: Ehara H, Kitazato H, Akanuma Y and Noda M designed the research; Ehara H, Yamamoto-Honda R, Kitazato H, Kawazu S and Akanuma Y collected the data; Takahashi Y contributed the analytical tools; Yamamoto-Honda R analyzed the data; Yamamoto-Honda R and Noda M wrote the paper.
Correspondence to: Dr. Ritsuko Yamamoto-Honda, Chief, Department of Diabetes and Metabolic Medicine and Diabetes Research Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan. rithonda@hosp.ncgm.go.jp
Telephone: +81-3-32027181 Fax: +81-3-52736930
Received: October 10, 2011
Revised: March 2, 2012
Accepted: March 9, 2012
Published online: March 15, 2012
Revised: March 2, 2012
Accepted: March 9, 2012
Published online: March 15, 2012
Core Tip